18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?

J Gastroenterol Hepatol. 2011 Apr;26(4):613-5. doi: 10.1111/j.1440-1746.2011.06625.x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biopsy
  • Contrast Media*
  • Fluorodeoxyglucose F18*
  • Humans
  • Image Interpretation, Computer-Assisted
  • Imaging, Three-Dimensional
  • Neoplasm Staging
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / diagnostic imaging
  • Pancreatic Neoplasms / surgery
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Preoperative Care
  • Radiopharmaceuticals*
  • Research Design*
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18